Skip to main content
SpringerLink
Log in

Technology in the Management of Type 1 and Type 2 Diabetes Mellitus: Recent Status and Future Prospects

  • Chapter
  • First Online:
Advances in Diabetes Research and Management

Abstract

Diabetes mellitus (DM), a metabolic condition with several causes, is characterized by persistent hyperglycemia and improper glucose, lipid, and protein metabolisms due to insulin deficiency. Type 1 diabetes mellitus (T1DM) treatment is improving. Most type 2 diabetes mellitus (T2DM) patients live in low- and middle-income countries, although most diabetes innovation research has been done in wealthier nations. Due to cost, health knowledge, and basic access, these folks cannot access most of these products. Glucose measurement and insulin delivery have improved results. Ensuring equal access to diabetes technologies across countries and socioeconomic groups is crucial. Data management tools will improve T1DM and T2DM services for all ages. T1DM and T2DM patients of all ages need more clinical trials. T2DM patients with severe insulin insufficiency who require exogenous insulin nevertheless struggle with glucose management. Safer, simpler insulin administration is needed clinically. Over the past decade, technology has made insulin treatment and disorder management safe. Highly customized insulin therapy for adult diabetics has shown significant results. New methods for the lower and middle classes are needed to increase device usage and improve the quality of life for those with inadequate technical skills or the elderly. This is crucial to promote treatment intensity and improve results. This must be tested in diabetic outpatients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • American Diabetes Asociation (ADA). (2021). Diabetes technology: Standards of medical care in diabetes—2021. Diabetes Care, 44(Suppl 1), S85–S99.

    Article  Google Scholar 

  • American Diabetes Association (ADA). (2015). Standards of medical Care in Diabetes—A bridged for primary Care providers. Clin Diabetes., 33(2), 97–111.

    Article  Google Scholar 

  • American Diabetes Association (ADA). (2017). Standards of medical care in diabetes-2017. Diabetes Care, 40(Suppl. 1), S1–S135.

    Google Scholar 

  • Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014). Type 1 diabetes. Lancet, 383, 69–82.

    Article  PubMed  Google Scholar 

  • Bailey, K. J., Little, J. P., & Jung, M. E. (2016). Self-monitoring using continuous glucose monitors with real-time feedback improves exercise adherence in individuals with impaired blood glucose: A pilot study. Diabetes Technology and Therapeutics, 18(3), 185–193.

    Article  CAS  PubMed  Google Scholar 

  • Battelino, T., Olsen, C. B., Schütz-Fuhrmann, I., Hommel, E., Hoogma, R., Schierloh, U., Sulli, N., & Bolinder, J. (2012). The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: A randomised controlled trial. Diabetologia, 55, 3155–3162.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bergenstal, R. M., Klonoff, D. C., Garg, S. K., Bode, B. W., Meredith, M., Slover, R. H., Ahmann, A. J., Welsh, J. B., Lee, S. W., & Kaufman, F. R. (2013). Threshold- based insulin- pump interruption for reduction of hypoglycemia. The New England Journal of Medicine, 369, 224–232.

    Article  CAS  PubMed  Google Scholar 

  • Blaslov, K., Naranda, F. S., Kruljac, I., & Renar, I. P. (2018). Treatment approach to type 2diabetes: Past, present and future. WJD., 9, 209–219.

    Article  PubMed  PubMed Central  Google Scholar 

  • Bogers, R. P., Bemelmans, W. J., & Hoogenveen, R. T. (2007). Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: A meta-analysis of21 cohort studies including more than 300000 persons. Arch Intern., 167, 1720–1728.

    Article  Google Scholar 

  • Bolinder, J., Antuna, R., Geelhoed-Duijvestijn, P., Kröger, J., & Weitgasser, R. (2016). Novel glucose- sensing technology and hypoglycaemia in type 1 diabetes: A multicentre, non- masked, randomised controlled trial. Lancet, 388, 2254–2263.

    Article  PubMed  Google Scholar 

  • Burckhardt, M. A., Smith, G. J., & Cooper, M. N. (2018). Real-world outcomes of insulin pumpcompared to injection therapy in a population-based sample of children with type 1 diabetes. Pediatric Diabetes, 19(8), 1459–1466.

    Article  CAS  PubMed  Google Scholar 

  • Cafazzo, J. A., Casselman, M., Hamming, N., Katzman, D. K., & Palmert, M. R. (2012). Design of an mHealth app for the self- management of adolescent type 1diabetes: A pilot study. Journal of Medical Internet Research, 14, e70.

    Article  PubMed  PubMed Central  Google Scholar 

  • Cappon, G., Vettoretti, M., & Sparacino, G. (2019). Continuous glucose monitoring sensors for diabetes management: A review of technologies and applications. Diabetes and Metabolism Journal, 43(4), 383–397.

    Article  PubMed  PubMed Central  Google Scholar 

  • Christopher, F., Catherine, S. M., & Jennifer, K. Y. (2020). Type 1 diabetes in youth and technology-based advances in management. Advances in Pediatrics, 67, 73–91. https://doi.org/10.1016/j.yapd.2020.04.002

    Article  Google Scholar 

  • Coda, A., Sculley, D., Santos, D., Girones, X., & Acharya, S. (2018). Exploring the effectiveness of smart Technologies in the Management of type 2 diabetes mellitus. Journal of Diabetes Science and Technology, 12(1), 199–201.

    Article  PubMed  Google Scholar 

  • Daly, A., & Hovorka, R. (2021). Technology in the management of type 2 diabetes: Present status and future prospects. Diabetes, Obesity & Metabolism, 23(8), 1722–1732.

    Article  CAS  Google Scholar 

  • Danne, T., Nimri, R., & Battelino, T. (2017). International consensus on use of continuous glucose monitoring. Diabetes Care, 40(12), 1631–1640.

    Article  PubMed  PubMed Central  Google Scholar 

  • Davies, M. J., D’Alessio, D. A., & Fradkin, J. (2018). Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of diabetes (EASD). Diabetologia, 61(12), 2461–2498.

    Article  PubMed  Google Scholar 

  • Defronzo, R. A. (2009). Banting lecture. From the triumvirate to the ominous octet: A new paradigm for the treatment of type 2 diabetes mellitus. Diabetes, 58(4), 773–795.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Deiss, D., Szadkowska, A., & Gordon, D. (2019). Clinical practice recommendations on the routine use of ever sense, the first long-term implantable continuous glucose monitoring system. Diabetes Technology & Therapeutics, 21(5), 254–264.

    Article  Google Scholar 

  • DiMeglio, L. A., Molina, C. E., & Oram, R. A. (2018). Type 1 diabetes. Lancet, 391, 2449–2462.

    Article  PubMed  PubMed Central  Google Scholar 

  • Dominguez-Bendala, J., Lanzoni, G., & Klein, D. (2016). The human endocrine pancreas: New insights on replacement and regeneration. Trends in Endocrinology and Metabolism, 27(3), 153–162.

    Article  CAS  PubMed  Google Scholar 

  • Dover, A. R., Stimson, R. H., Zammitt, N. N., & Gibb, F. W. (2017). Flash glucose monitoring improves outcomes in a type 1 diabetes clinic. Journal of Diabetes Science and Technology, 11, 442–443.

    Article  PubMed  PubMed Central  Google Scholar 

  • Duke, D. C., Barry, S., Wagner, D. V., Speight, J., Choudhary, P., & Harris, M. A. (2018). Distal technologies and type 1diabetes management. The Lancet Diabetes and Endocrinology, 6, 143–156.

    Article  PubMed  Google Scholar 

  • El-Kaissi, S., & Sherbeeni, S. (2011). Pharmacological Management of Type 2 diabetes mellitus: An update. Current Diabetes Reviews., 7, 392–405.

    Article  CAS  PubMed  Google Scholar 

  • Emperra Digital Diabetes Care. (2017). ESYSTA Personal and fully automatic. 2017. Accessed November 16, 2020. Available from https://www.emperra.com/en/esysta-product-system

  • Fagherazzi, G., & Ravaud, P. (2018). Digital diabetes: Perspectives for diabetes prevention, management and research. Diabetes & Metabolism, 1042, 1–8.

    Google Scholar 

  • Frias, J. P., Bode, B. W., Bailey, T. S., Kipnes, M. S., Brunelle, R., & Edelman, S. V. (2011). A16-week open-label, multicenter pilot study assessing insulin pump therapy in patients with type 2 diabetes sub optimally controlled with multiple daily injections. Journal of Diabetes Science and Technology, 5(4), 887–893.

    Article  PubMed  PubMed Central  Google Scholar 

  • Garg, V. (2011). Noninsulin pharmacological management of type1 diabetes mellitus. Indian Journal of Endocrinology and Metabolism, 15, S5–S11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gildon, B. W. (2018). InPen smart insulin pen system: Product review and user experience. Diabetes Spectrum: A Publication of the American Diabetes Association, 31(4), 354–358.

    Article  PubMed  Google Scholar 

  • Guh, D. P., Zhang, W., & Bansback, N. (2009). The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis. BMC Public Health, 9, 88.

    Article  PubMed  PubMed Central  Google Scholar 

  • Hellmund, R., Weitgasser, R., & Blissett, D. (2018). Cost calculation for a flash glucose monitoring system for adults with type 2 diabetes mellitus using intensive insulin-a UK perspective. Eur. Endocrinol., 14(2), 86–92.

    Article  PubMed  PubMed Central  Google Scholar 

  • Hoeks, L. B., Greven, W. L., & de Valk, H. W. (2011). Real- time continuous glucose monitoring system for treatment of diabetes: A systematic review. Diabetic Medicine, 28, 386–394.

    Article  CAS  PubMed  Google Scholar 

  • Hoss, U., & Budiman, E. S. (2017). Factory-calibrated continuous glucose sensors: The science behind the technology. Diabetes Technology & Therapeutics, 19(S2), S44–S50.

    Article  Google Scholar 

  • Hunter, C. M. (2016). Understanding diabetes and the role of psychology in its prevention and treatment. American Psychologist., 71, 515–525.

    Article  PubMed  Google Scholar 

  • International Diabetes Federation. (2020). IDF Diabetes Atlas, 9th ed., Brussels, Belgium. https://www.diabetesatlas.org. Accessed October 18, 2020.

  • Jonsson, S., Hedblad, B., & Engstrom, G. (2002). Influence of obesity on cardiovascular risk. Twenty-three-year follow-up of 22,025 men from an urban Swedish population. International Journal of Obesity and Related Metabolic Disorders, 26, 1046–1053.

    Article  CAS  PubMed  Google Scholar 

  • Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. (2008). Continuous glucose monitoring and intensive treatment of type 1 diabetes. The New England Journal of Medicine, 359, 1464–1476.

    Article  Google Scholar 

  • Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. (2010). Effectiveness of continuous glucose monitoring in a clinical care environment: Evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial. Diabetes Care, 33, 17–22.

    Article  Google Scholar 

  • Kaissi, S. E., & Sherbeeni, S. (2011). Pharmacological Management of Type 2 diabetes mellitus: An update. Current Diabetes Reviews., 7, 392–405.

    Article  PubMed  Google Scholar 

  • Katz, L. E. L., Bacha, F., Gidding, S. S., Weinstock, R. S., El-Ghormli, L., Libman, I., Nadeau, K. J., Porter, K., Marcovina, S., & McKay, S. (2018). Lipid profiles, inflammatory markers, and Insulin therapy in youth with type 2 diabetes. The Journal of Pediatrics, 196, 208–216.e2.

    Article  PubMed Central  Google Scholar 

  • Khunti, K., & Seidu, S. (2019). Therapeutic inertia and the legacy of dysglycemia on the microvascular and macrovascular complications of diabetes. Diabetes Care, 42, 349–351.

    Article  PubMed  Google Scholar 

  • Khunti, K., Wolden, M. L., Thorsted, B. L., Andersen, M., & Davies, M. J. (2013). Clinical inertia in people with type 2 diabetes: A retrospective cohort study of more than 80,000 people. Diabetes Care, 36(11), 3411–3417.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Klonoff, D. C. (2015). Cybersecurity for connected diabetes devices. Journal of Diabetes Science and Technology, 9(5), 1143–1147.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Klonoff, D. C., & Kerr, D. (2018). Smart pens will improve insulin therapy. Journal of Diabetes Science and Technology, 12(3), 551–553.

    Article  PubMed  PubMed Central  Google Scholar 

  • Lee, J. M., Newman, M. W., Gebremariam, A., Choi, P., Lewis, D., Nordgren, W., Costik, J., Wedding, J., West, B., Gilby, N. B., Hannemann, C., Pasek, J., Garrity, A., & Hirschfeld, E. (2017). Real-world use and self-reported health outcomes of a patient-designed do-it-yourself Mobile technology system for diabetes: Lessons for Mobile health. Diabetes Technology & Therapeutics, 19(4), 209–219.

    Article  Google Scholar 

  • Leslie, R. D. (2010). Predicting adult-onset autoimmune diabetes: Clarity from complexity. Diabetes, 59(2), 330–331.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Li, A., & Hussain, S. (2020). Diabetes technologies - what the general physician needs to know. Clinical Medicine (London, England), 20(5), 469–476.

    Article  PubMed  Google Scholar 

  • Luna, B., & Feinglos, M. N. (2001). Oral agents in the Management of Type 2 diabetes mellitus. American Family Physician, 63(9), 1747–1756.

    CAS  PubMed  Google Scholar 

  • Maahs, D. M., Calhoun, P., Buckingham, B. A., Chase, H. P., Hramiak, I., Lum, J., Cameron, F., Bequette, B. W., Aye, T., Paul, T., Slover, R., Wadwa, R. P., Wilson, D. M., Kollman, C., & Beck, R. W. (2014). A randomized trial of a home system to reduce nocturnal hypoglycemia in type 1 diabetes. Diabetes Care, 37(7), 1885–1891.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Magliano, D. J., Sacre, J. W., Harding, J. L., Gregg, E. W., Zimmet, P. Z., & Shaw, J. E. (2020). Young onset type 2 diabetes mellitus—Implications for morbidity and mortality. Nature Reviews. Endocrinology, 16, 321–331.

    Article  PubMed  Google Scholar 

  • Miller, C. K., Jean, J. L., Kristeller, L., Amy Headings, A., Nagaraja, H., & Miser, W. F. (2012). Comparative effectiveness of a mindful eating intervention to a diabetes self-management intervention among adults with type 2 diabetes: A pilot study. Journal of the Academy of Nutrition and Dietetics, 112(11), 1835–1842.

    Article  PubMed  PubMed Central  Google Scholar 

  • Monami, M., Lamanna, C., Marchionni, N., & Mannucci, E. (2010). Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: A meta- analysis. Acta Diabetologica, 47(Suppl. 1), 77–81.

    Article  CAS  PubMed  Google Scholar 

  • Montagnana, M., Caputo, M., Giavarina, D., & Lippi, G. (2009). Overview on self-monitoring of blood glucose. Clinica Chimica Acta, 402, 7–13.

    Article  CAS  Google Scholar 

  • Noh, R. M., Graveling, A. J., & Frier, B. M. (2011). Medically minimising the impact of hypoglycaemia in type 2 diabetes: A review. Expert Opinion on Pharmacotherapy, 12(14), 2161–2175.

    Article  CAS  PubMed  Google Scholar 

  • Novo Nordisk. (2020). Instructions for use: our pens and needles, 2019. Accessed November 19, 2020. Available from https://www.novonordisk.com/our-products/pens-and-needles/instructions-foruse.html.

  • Novo Nordisk Blue sheet. (2010). Quarterly perspective on diabetes and chronic diseases. Available from: http://www.press.novonordisk-us.com/bluesheet-issue2/downloads/NovoNordisk_Bluesheet_Newsletter.pdf.

  • Pendiq Intelligent Diabetes Care. (2020). PENDIQ 2.0. 2017. Accessed November 20, 2020. Available from https://pendiq.com/en/home/

  • Penfornis, A., Personeni, E., & Borot, S. (2011). Evolution of devices in diabetes management. Diabetes Technology & Therapeutics, 13, S93–S102.

    Article  Google Scholar 

  • Peyrot, M., Barnett, A. H., Meneghini, L. F., & Schumm-Draeger, P. M. (2012). Insulin adherence behaviours and barriers in the multinational global attitudes of patients and physicians in insulin therapy study. Diabetic Medicine, 29(5), 682–689.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pickup, J. C., Freeman, S. C., & Sutton, A. J. (2011). Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: Meta- analysis of randomised controlled trials using individual patient data. British Medical Journal, 343, d3805.

    Article  PubMed  PubMed Central  Google Scholar 

  • Pickup, J. C., Keen, H., & Parsons, J. A. (1978). Continuous subcutaneous insulin infusion: An approach to achieving normoglycaemia. British Medical Journal, 1(6107), 204–207.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pickup, J., Mattock, M., & Kerry, S. (2002). Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: Metaanalysis of randomised controlled trials. British Medical Journal, 324(7339), 705.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pickup, J. C., & Sutton, A. J. (2008). Severe hypoglycaemia and glycaemic control in type 1 diabetes: Metaanalysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabetic Medicine, 25, 765–774.

    Article  CAS  PubMed  Google Scholar 

  • Ramadasa, A., Queka, K. F., Chana, C. K. Y., & Oldenburgb, B. (2011). Web-based interventions for the management of type 2 diabetes mellitus: A systematic review of recent evidence. International Journal of Medical Informatics, 80, 389–405.

    Article  Google Scholar 

  • Reddy, M., Jugnee, N., Laboudi, A. E., Spanudakis, E., Anantharaja, S., & Oliver, N. (2018). A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with type 1 diabetes and impaired awareness of hypoglycaemia. Diabetic Medicine, 35, 483–490.

    Article  CAS  PubMed  Google Scholar 

  • Rewers, M. J., Pillay, K., de Beaufort, C., Craig, M. E., Hanas, R., Acerini, C. L., & Maahs, D. M. (2014). ISPAD clinical practice consensus guidelines 2014. Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatric Diabetes, 15(Suppl. 20), 102–114.

    Article  CAS  PubMed  Google Scholar 

  • Rodbard, D. (2017). Continuous glucose monitoring: A review of recent studies demonstrating improved glycemic outcomes. Diabetes Technology & Therapeutics, 19(Suppl 3), S25–S37.

    Article  Google Scholar 

  • Roze, S., Duteil, E., & Smith-Palmer, J. (2016). Cost-effectiveness of continuous subcutaneous insulin infusion in people with type 2 diabetes in the Netherlands. Journal of Medical Economics, 19(8), 742–749.

    Article  CAS  PubMed  Google Scholar 

  • Sangave, N. A., Aungst, T. D., & Patel, D. K. (2019). Smart connected insulin pens, caps, and attachments: A review of the future of diabetes technology. Diabetes Spectrum: A Publication of the American Diabetes Association, 32(4), 378–384.

    Article  PubMed  Google Scholar 

  • Seidu, S., Cos, X., Brunton, S., Harris, S. B., Jansson, S. P. O., Cases, M. M., Neijens, A. M. J., Topsever, P., & Khunti, K. (2021). A disease state approach to the pharmacological management of Type2 diabetes in primary care: A position statement by primary Care diabetes Europe. Primary Care Diabetes, 15(1), 31–51.

    Article  CAS  PubMed  Google Scholar 

  • Shah, V. N., Moser, E. G., Blau, A., Dhingra, M., & Garg, S. K. (2013). The future of basal insulin. Diabetes Technology & Therapeutics, 15, 727–732.

    Article  CAS  Google Scholar 

  • Shah, R. B., Patel, M., Maahs, D. M., & Shah, V. N. (2016). Insulin delivery methods: Past, present and future. International Journal of Pharmaceutical Investigation, 6(1), 1–9.

    Article  PubMed  PubMed Central  Google Scholar 

  • Sherr, J. L., Hermann, J. M., Campbell, F., Foster, N. C., Hofer, S. E., Allgrove, J., Maahs, D. M., Kapellen, T. M., Holman, N., Tamborlane, W. V., Holl, R. W., Beck, R. W., & Warner, J. T. (2016). Use of insulin pump therapy in children and adolescents with type 1 diabetes and its impact on metabolic control: Comparison of results from three large, transatlantic paediatric registries. Diabetologia, 59, 87–91.

    Article  CAS  PubMed  Google Scholar 

  • Singhal, S., & Kumar, S. (2021). Current perspectives on Management of Type 2 diabetes in youth. Children, 8(1), 37.

    Article  PubMed  PubMed Central  Google Scholar 

  • Tamborlane, W. V., Sherwin, R. S., & Genel, M. (1979). Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. The New England Journal of Medicine, 300(11), 573–578.

    Article  CAS  PubMed  Google Scholar 

  • Tauschmann, M., & Hovorka, R. (2018). Technology in the management of type 1 diabetes mellitus-current status and future prospects. Endocrinology, Macmillan Publishers Limited, Part of Springer Nature.

    Book  Google Scholar 

  • Trawley, S., Browne, J. L., Hagger, V. L., Hendrieckx, C., Holmes-Truscott, E., Pouwer, F., Skinner, T. C., & Speight, J. (2016). The use of Mobile applications among adolescents with type 1 diabetes: Results from diabetes MILES youth—Australia. Diabetes Technology & Therapeutics., 18(12), 1–7.

    Article  Google Scholar 

  • Vallejo Mora, M. D. R., Carreira, M., Anarte, M. T., Linares, F., Olveira, G., & Romero, S. G. (2017). Bolus calculator reduces hypoglycemia in the short term and fear of hypoglycemia in the long term in subjects with type 1diabetes (CBMDI study). Diabetes Technology & Therapeutics, 19, 402–409.

    Article  CAS  Google Scholar 

  • Weisman, A., Bai, J. W., Cardinez, M., Kramer, C. K., & Perkins, B. A. (2017). Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: A systematic review and meta-analysis of outpatient randomised controlled trials. The Lancet Diabetes and Endocrinology, 5, 501–512.

    Article  CAS  PubMed  Google Scholar 

  • Weiss, R., Garg, S. K., Bode, B. W., Bailey, T. S., Ahmann, A. J., Schultz, K. A., Welsh, J. B., & Shin, J. J. (2015). Hypoglycemia reduction and changes in hemoglobin A1c in the ASPIRE in-home study. Diabetes Technology & Therapeutics, 17, 542–554.

    Article  CAS  Google Scholar 

  • Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004). Global prevalence ofdiabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care, 27(5), 1047–1053.

    Article  PubMed  Google Scholar 

  • Wong, J. C., Neinstein, A. B., Spindler, M., & Adi, S. (2015). A minority of patients with type 1 diabetes routinely downloads and retrospectively reviews device data. Diabetes Technology & Therapeutics, 17, 555–562.

    Article  CAS  Google Scholar 

  • Yaron, M., Roitman, E., & Aharon-Hananel, G. (2019). Effect of flash glucose monitoring technology on glycemic control and treatment satisfaction in patients with type 2 diabetes. Diabetes Care, 42(7), 1178–1184.

    Article  CAS  PubMed  Google Scholar 

  • YDS Delivery Systems. (2020). Smart Pilot-Transforming YpsoMate into a smart product system, 2020. Accessed November 19, 2020. Available from https://yds.ypsomed.com/en/injection-systems/smartdevices/smartpilot-for-ypsomate.html.

Download references

Author information

Authors and Affiliations

  1. Department of Chemistry, Gurudas College, Kolkata, West Bengal, India

    Titas Biswas

  2. Department of Zoology, Siliguri College, Siliguri, West Bengal, India

    Biplab Kumar Behera

  3. Department of Zoology, Acharya Prafulla Chandra College, New Barrackpore, West Bengal, India

    Nithar Ranjan Madhu

Authors
  1. Titas Biswas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Biplab Kumar Behera
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nithar Ranjan Madhu
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Faculty of Dentistry Department of Biochemistry, Jamia Millia Islamia, New Delhi, India

    Rana Noor

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Biswas, T., Behera, B.K., Madhu, N.R. (2023). Technology in the Management of Type 1 and Type 2 Diabetes Mellitus: Recent Status and Future Prospects. In: Noor, R. (eds) Advances in Diabetes Research and Management. Springer, Singapore. https://doi.org/10.1007/978-981-19-0027-3_6

Download citation

Publish with us

Policies and ethics

Search

Navigation